EAGLE PHARMACEUTICALS, INC. 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Jan 5, 2016
Insider Transaction Report
Form 4
Hepner Adrian
Executive VP
Transactions
- Award
Stock Option (right to buy)
2016-01-04+62,100→ 62,100 totalExercise: $86.15Exp: 2026-01-03→ Common Stock (62,100 underlying)
Footnotes (1)
- [F1]The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 4, 2017, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.